Tear film breakup time assessment is an integral component of dry eye evaluation. To our knowledge, the comparative discriminative ability of the noninvasive Keratograph (Oculus) vs conventional fluorescein method in detecting dry eye is unknown.
T ear film breakup time measurement is a central component of dry eye assessment. 1 Although topical instillation of sodium fluorescein via impregnated strips is commonly used to visualize breakup, 2 it is recognized that it reduces tear film stability. 3 Recently, the Tear Film and Ocular Surface Society Dry Eye Workshop (TFOS DEWS II) recommended using automated noninvasive measurement techniques that allow for an objective assessment of the undisturbed tear film. 1 The Keratograph 5M
(Oculus) is a noninvasive corneal topographer that measures noninvasive breakup time by detecting distortion in the contours of reflected Placido disc mires using an automated realtime videokeratoscopy analysis. 1 The noninvasive technique may potentially be superior to the conventional fluorescein method by avoiding the tear film destabilization that is associated with fluorescein instillation. 1, 3 This randomized study sought to compare clinical tear film stability measurements obtained from the automated noninvasive keratograph with conventional fluorescein methods and evaluate their respective discriminative ability in detecting dry eye.
Methods
This investigator-masked randomized crossover trial adhered to the tenets of the Declaration of Helsinki and received institutional ethics committee approval from the University of Auckland. The trial protocol is available in the Supplement. Participants were required to be 18 years or older with no history of uncontrolled major systemic disease, surgical procedures, or use of systemic/topical medications known to affect the eye within 3 months of study participation. Seventy-four participants provided written consent and were randomized into 2 equally sized age, sex, and race/ethnicity-matched groups, with and without symptomatic dry eye, between May 26, 2016, and October 3, 2016. This satisfied nonparametric power calculations (n = 62, β = 0.2, α = .05, difference = 5 seconds, SD = 7 seconds). Dry eye classification was made according to an Ocular Surface Disease Index (OSDI) score of 13 or greater. 1, 4 Two independent observers measured right eye tear film breakup time in triplicate, respectively, in a randomized order ( Figure 1 ), using noninvasive automated keratograph readings (noninvasive keratograph breakup time [NIKBUT]), and under blue light with a Wratten yellow filter following instillation of a drop (10 μl) of fluorescein from a wetted impregnated strip (Haag-Streit) that was shaken to remove excess fluid (fluorescein breakup time [TBUT] ).
5 A 30-minute interval between measurements ensured subsidence of reflex tearing. Statistical analysis was performed using Prism, version 6.02 (GraphPad). Non-normally distributed NIKBUT and TBUT measurements were logarithmically transformed to fulfill D'Agostino-Pearson normality testing before the parametric analysis.
3 Intragroup and intergroup comparisons were conducted with paired and unpaired t tests, respectively, and variances were analyzed by F tests. A Bland-Altman analysis between stability measurements 6 and a Pearson correlation analysis with OSDI were performed. Receiver operative characteristic curves were constructed to assess the discriminative ability of the 2 measurements in detecting dry eye. The area under the curve (C statistic), and Youdenoptimal diagnostic cutoff sensitivity and specificity were then calculated. All tests were 2-tailed, and P < .05 was considered significant. Significant positive correlations were observed between NIKBUT and TBUT in both the dry eye group (Pearson r = 0.42; 95% CI, 0.09-0.67; P = .001) and the controls (Pearson r, 0.55; 95% CI, 0.29-0.73; P < .001). Reverse transformation of BlandAltman biases showed that, on average, NIKBUT was 1.6 (95% limits of agreement, 0.3-8.1) times that of TBUT in dry eye, and 2.1 (95% limits of agreement, 0.6-8.1) times in healthy participants. The OSDI score was significantly correlated with both NIKBUT (Pearson r, −0.32; 95% CI, −0.51 to −0.10, P = .005) and TBUT (Pearson r, −0.26; 95% CI, −0.46 to −0.03; P = .03).
Results
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Receiver operative characteristic curves for the discriminative ability of NIKBUT and TBUT in detecting dry eye are illustrated in Figure 2 . The discriminative ability of NIKBUT (C statistic, 0.68; 95% CI, 0.56-0.81, P = .007) was greater than TBUT (C statistic, 0.57; 95% CI, 0.44-0.70; P = .31).
The optimal diagnostic cutoff for NIKBUT was 9 seconds or less with a sensitivity of 68% (95% CI, 50%-82%), specificity of 70% (95% CI, 53%-84%), positive likelihood ratio of 2.27 (95% CI, 1.32-3.91), and negative likelihood ratio of 0.46 (95% CI, 0.28-0.77). The optimal threshold for TBUT was 5 seconds or less with a sensitivity of 54% (95% CI, 37%-71%), specificity of 68% (95% CI, 50%-82%), positive likelihood ratio of 1.67 (95% CI, 0.96-2.89), and negative likelihood ratio of 0.68 (95% CI, 0.45-1.03).
Discussion
The results demonstrate significantly shorter and more narrowly distributed TBUT measurements than NIKBUT in both participant groups. Noninvasive keratograph breakup time displayed greater discriminative ability in detecting dry eye than TBUT.
Strengths and Limitations
However, this study is not without limitations. Predominantly younger East Asian and European participants were randomized, and eligibility required participants to have no uncontrolled major systemic disease, surgical procedures, or topical/systemic medication use known to affect the eye 3 months before study participation. This may affect the applicability of study findings to other demographic populations or to the secondary and iatrogenic dry eye conditions that were excluded. 7, 8 Nevertheless, the median NIKBUT measurements were significantly longer than TBUT, consistent with previously reported tear film destabilization effects of fluorescein instillation.
1,3 Interestingly, the difference was smaller in participants with dry eye, which may be associated with the positively skewed nature of both measurements. 3, 9 This was supported by a Bland-Altman analysis that showed that NIKBUT was, on average, 1.6 and 2.1 times TBUT in the dry eye and control groups. The distributions of TBUT measurements were narrower than NIKBUT with smaller interparticipant variability, potentially reflecting a global reduction of stability measurements following fluorescein instillation.
3 This global reduction may also contribute toward the significant correlations that were observed between NIKBUT and TBUT, which were concordant with an earlier report. 9 However, in both groups, the relatively wide Bland-Altman limits of agreement suggested poorer levels of clinical agreement between the 2 measurements. Interestingly, the limits of agreement were narrower than those reported in a previous study that compared NIKBUT with stability measurements following micropipette instillation of a smaller volume of fluorescein (5 μl). 9 Differences in reflex tearing and fluorescein concentrations achieved by micropipette instillation may potentially contribute. To our knowledge, the comparative discriminative abilities of NIKBUT vs TBUT in detecting dry eye have not been previously established. In the current study, NIKBUT displayed superior discriminative ability with a greater C statistic, higher optimal diagnostic accuracy, and stronger correlation with OSDI scores. Furthermore, a significant difference in NIKBUT, but not TBUT, was detected between participants with dry eye and healthy participants. Interestingly, although the optimal diagnostic cutoff for NIKBUT (≤9 seconds) reflected the recommendations from the TFOS DEWS II (<10 seconds), 1 the optimal threshold for TBUT was significantly lower (≤5 seconds). The superior discriminative ability of NIKBUT may be related to the lesser degree of overlap in the 95% CIs between participant groups. Nonetheless, the small intergroup overlap in the 95% CIs of NIKBUT was likely to contribute to the modest sensitivity and specificity values of around 70%. This may reflect the complex interrelationship between tear film function, ocular surface inflammation, and somatosensory pathways in dry eye development.
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Conclusions
Conventional fluorescein tear film stability measurements were significantly shorter with narrower distributions, while automated noninvasive keratograph readings demonstrated superior discriminative ability in detecting dry eye. 
Study design
Prospective, investigator-masked, randomised crossover study Population A minimum of 62 participants will be recruited into two equal-sized age, gender, and ethnicity-matched groups, with and without symptomatic dry eye (Ocular Surface Disease Index ≥13).
Intervention
The tear film breakup time of participants will be assessed in triplicate, with and without sodium fluorescein instillation (TBUT and NIKBUT), in a randomised order, by two independent observers to ensure investigator masking. A 30-minute interval between measurements will ensure for subsidence of any reflex tearing.
In the intervention arm, sodium fluorescein will be applied to the bulbar conjunctiva from a fluorescein impregnated strip (Haag-Streit) wetted with 1 drop (10 l) of saline and shaken to remove excess fluid. Following fluorescein instillation, participants will be instructed to blink naturally over a 1 minute period to facilitate even distribution over the ocular surface. Tear film breakup time will then be assessed in triplicate under blue light with a Wratten yellow filter.
In the control arm, tear film breakup time will be measured using an automated non-invasive measurement technique (Oculus Keratograph® 5M, Germany) without sodium fluorescein instillation.
Outcome measures
 Fluorescein breakup time (TBUT)  Non-invasive Keratograph ® breakup time (NIKBUT)  Area under ROC curve of TBUT, NIKBUT in detecting dry eye.  Youden-optimal diagnostic cut-off sensitivity and specificity of TBUT and NIKBUT in detecting dry eye.
Statistical plan
Non-parametric adjusted power calculations showed that a minimum of 31 participants was required in each of the two participant groups, with and without dry eye. The distributions of NIKBUT and TBUT measurements will undergo D'Agostino-Pearson omnibus normality testing and logarithmic transformation before further parametric analysis if necessary. Intra-group and inter-group comparisons of the medians of TBUT and NIKBUT will be conducted using paired and unpaired t-tests, and the F-test for variances will be performed. BlandAltman analysis will be conducted between TBUT and NIKBUT time measurements, and Pearson's correlation analysis between TBUT, NIKBUT, and OSDI. ROC curves analysis and Youden-optimal cut-off sensitivity and specificity of TBUT and NIKBUT in detecting dry eye will be reported. 
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This study is a prospective, investigator-masked, randomised crossover study evaluating clinical 
74
Disease Index questionnaire will be administered at enrolment, and a cut-off score of ≥13 will be 75 used for the purposes of dry eye classification.
77
The tear film breakup time of participants will be assessed in triplicate, with and without sodium 78 fluorescein instillation, in a randomised order, by two independent observers to ensure 79 investigator masking. A 30-minute interval between measurements will ensure for subsidence of 80 any reflex tearing.
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In the intervention arm, sodium fluorescein will be applied to the bulbar conjunctiva from a 
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In the control arm, tear film breakup time will be measured using an automated non-invasive 103 104 105
Eligibility Criteria
107
Subjects must meet the following criteria to be eligible for inclusion in the study:
108
 Age of 18 years or older.
109
 No history of uncontrolled major systemic disease known to affect the eye (e.g.
110
uncontrolled severe systemic allergy, autoimmune or immunodeficiency disease).
111
 No history of ocular surgery (such as refractive or cataract surgery) in either eye during 112 the preceding 3 months.
113
 No use of topical or systemic medications known to cause ocular drying (e.g.,
114
cyclosporine, antihistamines, tricyclic antidepressants, anxiolytics, antimuscarinics,
115
diuretics, phenothiazines, steroids, etc.) during the preceding 3 months.
116
 Able to provide written informed consent.
117 118 119
Informed Consent
121
Prior to study enrolment, participants will be provided with a participant information sheet and 122 consent form and be given the chance to review and ask questions before written informed 123 consent is obtained. The participant will sign and date the informed consent form. The original 124 will be retained with the principal investigator, independently of the data, and a copy will be 125 provided to the participant. 
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 The overall distribution of the two tear film stability measurements will be compared using
158
the F-test for variances.
159
 Pearson's correlation analysis between the two tear film stability measurements and the
160
Ocular Surface Disease Index will be performed.
161
 Bland-Altman analysis will be conducted between the two tear film breakup time 
180
The investigator will also ensure that participants undergo no procedures other than those 
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The principles of informed consent described in the International Conference on Harmonisation
191
(ICH) guidelines for Good Clinical Practice (GCP) will be followed.
193
Eligible subjects may only be included in the study after providing written (witnessed, where 
203
The investigator will retain source documents for each subject in the study. The investigator will 204 also retain the original informed consent form signed by subject, and a copy will be given to the 205 participant for their records.
206 207 208
Subject Confidentiality and Data Protection
210
The investigator will take all appropriate measures to ensure that the anonymity of each study 211 subject is maintained. The personal data of study participants will be treated in compliance with 212 all applicable legal, regulatory, and institutional requirements. 
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Prior to study commencement, the investigator is required to sign a protocol signature page 
236
The investigator will not implement a change in the design or operation of the study protocol,
237
proposed informed consent form and participant information sheet without an Institutional
238
Review Board/Independent Ethics Committee/Research Ethics Board approved amendment.
240
Any change or addition to the protocol can only be made in a written protocol amendment that 
259
All records will be retained for 6 years after study completion and de-identified electronic data 
